Skip to search formSkip to main contentSkip to account menu

Singulair

Known as: Merck brand of montelukast sodium, Merck Sharp & Dohme brand of montelukast sodium, Cahill May Roberts brand of montelukast sodium 
National Institutes of Health

Related topics

Related topics

5 relations

Broader (3)

Acetic Acid Estersmontelukastmontelukast sodium
MK 0476montelukast 4 MG Chewable Tablet [Singulair]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Curative effect of singulair combined with methylprednisolone in treatment of mycoplasma pneumonia and the effect on inflammatory response and peripheral blood lymphocyte subset content
Curative effect of singulair combined with methylprednisolone in treatment of mycoplasma pneumonia and the effect on inflammatory… 
2016
2016
Assessment of Bioequivalence of Fexofenadine and Montelukast Fixed Dose Combination Tablet Versus Separate Formulations of the Individual Components at the Same Dose Levels
This study was performed to assess the bioequivalence of fexofenadine 120 mg+montelukast 10 mg fixed dose combination (Allegra™ M… 
2012
2012
Discovery and Development of Montelukast (Singulair
2012
2012
Anti-cholinergic effect of singulair on isolated rat’s tracheal smooth muscle
Singulair (Montelukast) is a potent and selective leukotriene D4 receptor antagonist, often used in treating inflammatory… 
2009
2009
Singulair-induced anaphylaxis?
2003
2003
Montelukast does not protect against hyperoxia‐induced inhibition of alveolarization in newborn rats
Impaired lung development has been demonstrated in neonatal animals exposed to hyperoxia. High lung cys‐leukotriene levels may be… 
2002
2002
Treatment of asthmatic patients with a cysteinyl leukotriene receptor‐1 antagonist montelukast (Singulair), decreases the eosinophil survival‐enhancing activity produced by peripheral blood…
Background: Montelukast (Singulair, MSD) has been shown to have a beneficial effect on the clinical symptoms of asthma. We aimed… 
2002
2002
[Pharmacological profile and clinical effects of montelukast sodium (Singulair chewable tablet), an antiasthmatic agent].
Montelukast (Singulair) is an antiasthmatic agent that has the chemical structure of a quinoline. Montelukast has a high affinity… 
1998
1998
A novel photoaffinity probe for the LTD4 receptor.
1998
1998
A series of non-quinoline cysLT1 receptor antagonists: SAR study on pyridyl analogs of Singulair.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)